Www.global-campaign.org Rectal Microbicides: New Hope for HIV and STD Prevention.

Slides:



Advertisements
Similar presentations
No one left behind: Increased coverage, better programmes and maximum impact for key populations WHO Consolidated Guidelines on HIV Prevention, Diagnosis,
Advertisements

What is up with Nonoxynol-9? Global Campaign for Microbicides
HIV treatment as prevention Stephen Kegg. 2 Learning Outcomes Overview of HIV management HIV transmission risks Current prevention strategies Which new.
Cristin Muecke, RMOH Nick Scott, ED AIDS NB.  Why HIV testing remains important  Treatment as prevention  Discuss advantages/disadvantages of various.
Dr. Carol Odula (Obs./Gyn.) May 7 th 2013 Preparing for pre-exposure prophylaxis (PrEP) to prevent HIV infection.
HIV CENTER for Clinical and Behavioral Studies MAIN POINTS ACKNOWLEDGMENTS This research was supported by a NIMH grant (R ; PI, Alex Carballo-Diéguez,
Preparing for pre-exposure prophylaxis (PrEP) to prevent HIV infection James Wilton Project Coordinator Biomedical Science of HIV Prevention
HIV in Texas: The Ways Forward Ann Robbins Manager of HIV/STD Prevention and Care Department of State Health Services.
Rectal Microbicides: The Basics Date, Location Your name, Your affiliation.
New York State Department of Health AIDS Institute June, 2014
The Open Door to Cancer A Public Health Concern
Are people living with HIV less likely to pass HIV to others if they are on treatment? Exploring the use of treatment as prevention James Wilton Project.
Dr Himani. Foams or creams that people can use in vagina or rectum during sex to prevent transmission Currently, there is no vaccine to prevent HIV. This.
Rectal Microbicides: The Basics Date, Location Your Name, Organization.
The 4 th Decade of the HIV Epidemic: Midwest Regional Response September 17, 2013 with Jim Pickett, AFC/IRMA The Bottom Line on Rectal and Vaginal Microbicide.
Jim Pickett, IRMA/AFC GMHC – January 23, 2013 The Bottom Line on Rectal Microbicide Research.
Midwest AIDS Training & Education Center Health Care Education & Training, Inc. HIV/AIDS Case-Finding In Family Planning Clinics.
HIV/AIDS Presented by Kunphen center for substance dependence and HIV/AIDS.
Rectal Microbicides: The Basics October 2008, ESM Marc-André LeBlanc, GCM.
Adult Viral Hepatitis Update Roxanne Ereth, MPH, BS Hepatitis C Program Manager Adult Viral Hepatitis Prevention Coordinator.
STI Screening & Prevention NIKPOUR Learning Objectives  Describe the guidelines for STI screening  Describe the guidelines for partner notification.
Introduction to HIV New Prevention Technologies (NPTs)
Microbicides: New Hope for Prevention of HIV and other STIs
© 2011 McGraw-Hill Higher Education. All rights reserved. Presentation Package for Concepts of Fitness & Wellness 9e Concept 21 Preventing Sexually Transmitted.
Microbicides: Who, what, where, when and how Rebekah Webb Global Campaign for Microbicides © Salam Dahbor,
Cindra Feuer and Marc-André LeBlanc HRCF, 21 April 2010 ARV-based Prevention.
Raising Consciousness Creating Awareness Behaviour Change Communication CHETNA STRC Ahmedabad.
Rectal Microbicides: New Hope for Non-Condom Prevention of HIV and other STDs.
SEXUALLY TRANSMITTED DISEASES
Biomedical Approaches to HIV Prevention HIV Research Catalyst Forum April 21, 2010, Baltimore, MD Monica S. Ruiz, PhD, MPH George Washington University.
The HIV virus. The overwhelming majority of people with HIV live in low- and middle-income countries. Sub- Saharan Africa accounts for two-thirds.
Microbicides: Science, research, and overview of the field Dr Kamini Walia, Indian Council of Medical Research, New Delhi Bindiya Patel, Global Campaign.
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System HIV in the United Kingdom: 2012 Overview.
Resource Needs Model Rachel Sanders October 28 th, 2010.
Microbicides: What will they do? What will they be like? What needs to be done? Richard A. Cone Johns Hopkins University ReProtect, LLC (“BufferGel™” &
National Working Group on Microbicides The Basics of Microbicides Amitrajit Saha PATH January 2007.
National Working Group on Microbicides Rectal microbicides: The political landscape Ananthy Thambinayagam, MPH Global Campaign for Microbicides Rectal.
National Working Group on Microbicides RECTAL MICROBICIDES RESEARCH CURRENT STATUS & CHALLENGES Dr. Badri N. Saxena, M.D., F.A.M.S. Professor, Centre for.
UK Campaign for Microbicides Rectal microbicides Need, development and advocacy Kim Mulji Executive Director Naz Foundation.
HIV Prevention : Why we need more options for women Wanjiku Kamau Consultant: International AIDS Vaccine Initiative Consultant: International Partnership.
Partnering to Promote Female-controlled HIV Prevention Methods Matthews J, Becker J, Massey C, Jacobsen J, Patel B Ibis Reproductive Health, International.
Rectal microbicides, where are we? Kim Mulji Naz Foundation International.
JOSEPH O’REILLY Deputy Chief Executive REBEKAH WEBB Policy Officer IN COLLABORATION WITH THE GLOBAL CAMPAIGN FOR MICROBICIDES IS THERE AN INVISIBLE CONDOM.
Implications of Anal Intercourse and Rectal use of Products in Vaginal Microbicide Trials Ian McGowan MD PhD FRCP.
“AIDS has a woman’s face” -In Sub-Saharan Africa, nearly 60% of people living with HIV/AIDS are women -Teenage girls in parts of.
The Transmission Puzzle and STD-HIV Connection. 2 Understanding Risk  What are my chances of getting HIV or other STDs through sexual contact?  How.
A Jo Robinson, Terrence Higgins Trust in cooperation with the Global Campaign for Microbicides Topical.
Microbicides: New Hope for Prevention of HIV and other STIs Pamina M. Gorbach UCLA- SPH & Medicine.
Gel or Suppositories? Results of a Rectal Microbicide Formulation Preference Trial Alex Carballo-Diéguez 1, Curtis Dolezal 1, Jose A. Bauermeister 1, Ana.
Measuring Anal Intercourse in Vaginal Microbicide Studies/Trials
Topical Microbicides: New Hope for Non-Condom Prevention of HIV and other STDs Your name here on behalf of the Global Campaign.
A pill to prevent HIV? For women??
New ARV-based prevention tools how the research is happening how we need to be involved Anna Forbes, MSS Consultant, HIV and women’s health HIV Research.
Rectal microbicides advocacy Issues, work and collaboration Kim Mulji UK rectal microbicides working group.
A people-centred perspective Dr Roger Tatoud Imperial College London IRMA Global Teleconference 4 December 2009.
Looking Ahead to MTN-017 Ross D. Cranston MD, FRCP Microbicide Trials Network IRMA.
New Prevention Technologies Workshop Module 2: NPTs in context
ARV-Based Prevention What it means for women Your name here
International Aid Towards HIV/AIDs in sub-Saharan Africa Ally H. Van Valen.
CHAIN OF INFECTION STI POINT OF VIEW.
HIV Prevention: A Winnable Battle Centers for Disease Control and Prevention.
Microbicides: New Hope for Prevention of HIV and other STIs Your name here
Information about HIV Prevention Options
“Its Different Now”: The Changing Landscape of HIV testing
Rectal Microbicides: Where We’re Heading
HIV 101 Dr Sindisiwe van Zyl
Microbicides: Who, what, where, when and how
José Bauermeister PhD, MPH University of Pennsylvania MTN BRWG Member
Rectal Microbicides: New Hope for HIV and STD Prevention
Presentation transcript:

Rectal Microbicides: New Hope for HIV and STD Prevention

Why we need rectal microbicides What is involved in development Where the research is What you can do to get involved Objectives

Men at risk High rates of condom use are difficult to maintain, as the rate of new HIV infections shows New data reveals reasons for concern: –UK: 48.8% UAI in the past year –US: 30% UAI (HIV - men in past year) STD rates confirm UAI prevalence

Women at risk In large US survey, 35% of women age report having had anal sex at some time in their life 32% of high-risk women reported anal sex in past 6 months (Gross et al, 2000)

What is a microbicide? Microbicides are substances that can reduce the transmission of HIV and other STD pathogens when applied vaginally and, possibly, rectally. They are not yet available. Currently, they are formulated as lubes, gels or creams applied with an applicator like those shown here

We need a product that is… Inexpensive Easily accessible (over the counter) Easy to use Safe, non-irritating Available in various forms (in lubes, suppositories, on condoms) Effective

What if we had a complete HIV toolkit? Prior to exposure Point of transmission Treatment Male and female condoms and lube ART to prevent perinatal transmission Clean injecting equipment Vaginal and rectal microbicides Cervical barriers Post-exposure prophylaxis (PEP) Improved antiretroviral therapy Treatment for opportunistic infections Basic care/nutrition Prevention for positives Education and behavior change Therapeutic vaccines Rights-focused behaviour change Voluntary counselling and testing STI screening and treatment Male circumcision Preventative Vaccines Pre-exposure prophylaxis (PREP)

Why vaginal microbicides? Women currently have no way to protect themselves when her partner won’t use a condom Women biologically more vulnerable to HIV –2-4 times more likely than men to get HIV from vaginal sex Women may be less able to assert their rights Current methods (abstinence, fidelity, and condom use) often require male consent, knowledge, or cooperation

Laboratory Testing 2-6 Years Phase 3 (efficacy) 2 to 4 Years Simultaneous studies in some cases: HIV+, penile & rectal safety 10 or more years 3 products 4 products 30+ products Phase 1 (safety) 1 to 6 Months Phase 2 (safety) Up to 2 Years 25 – 40 people people 3,000-10,000 people Vaginal Microbicide Research in 2005

How could microbicides work? Kill/inactivate/immobilize the virus Boost body’s natural defenses Prohibit viral entry by blocking fusion Inhibit viral replication Create a physical barrier or some combination of these approaches

Physiological Differences VaginaRectum Most of the epithelium is 40 cell layers thick Very fragile epithelium, 1 cell layer thick. Fewer CD4 cells than rectum More inflammatory cells under surface (CD4 receptors) Acidic pHAlkaline, rather than acidic pH Enclosed pouchOpen-ended tube

Anatomy 101

Research questions Infection – more to learn about anal intercourse and HIV infection Testing - What assays (tests) to measure impact? Distribution – how would it spread? Application Methods? Dosing – how much, what is acceptable? How does rectal shedding of HIV impact risk?

Laboratory research To learn more about: How HIV infection occurs in the rectum – what cells are most vulnerable The impact of intercourse on rectal tissue (trauma, inflammation, speed of healing) What markers can we look at to determine impact of a product on the rectum?

Laboratory research in action Dr. Ian McGowan, HPTN 056 University of California/Los Angeles Goal: To define measurements that can be made on rectal tissue biopsies that would be of use in rectal microbicide safety studies. Repeated measurements on 16 men, and studied variation based on: –Time –Location in the rectum –Sero status

Penile Acceptability Studies To learn more about… How much tissue is likely to be exposed to a microbicide Impact of a product on the penis

Distribution research in action: Dr. Craig Hendrix at Johns Hopkins University in Baltimore Volunteers simulated anal intercourse MRI scans done up to five hours after its release Initial studies suggest that semen could travel up to 60 centimeters Showed where a microbicide would be needed to protect vulnerable tissues

Behavioral Research To learn more about… Prevalence of anal intercourse for both mean and women – and how many of these acts are protected Preferences re: formulation and delivery systems Sexual practices that affect microbicide feasibility How much product is acceptable

Behavioral research in action: Alex Carballo-Diéguez, Columbia Univ (NY) Ken Mayer, Fenway Community Health (Boston) How much gel is tolerable? 18 HIV uninfected men Maximum acceptable dose for insertion and anal intercourse

Behavioral research in action: Alex Carballo-Diéguez and Sigma Research Center both did surveys of MSM interest in using microbicide Results: In San Francisco: 59% heard of microbicides, 25% - 35% might use (depending on stated effectiveness) In the UK: 23% had heard of microbicides, 59% might use

More vital steps 1.Men and women need education about the risks of unprotected anal sex 2.Safety trials on rectal application of vaginal microbicides that are currently in large scale trials 3.Testing over the counter lubes to see how safe they are 4.Advocacy for increased research

Rectal safety trials on vaginal products We won’t know if the first vaginal microbicides are effective for rectal use But we must know if they are safe to put in the rectum or not Because some people will try to use them rectally If deemed harmful for the rectum, labels warning against rectal use are imperative.

Testing on over the counter lubes Drs. Sudol & Phillips at Population Council, New York Tested 5 OTC lubes in mice to see if they caused damage to rectal cells KY-Plus (no longer on market) and DeLube caused the most damage Viamore, Vagisil and Astroglide caused some damage More research is underway, with findings expected soon. Need more research to see if these products cause damage to human rectal cells

Online Lube Survey 7,500 participants from 100 countries 700 women Data analysis by UCLA Information on condom and lubricant use, rectal microbicide acceptability Help establish priorities for testing lubes for rectal safety

Microbicide research is drastically under- funded Need for increased funding for both vaginal and rectal microbicides –Talk to your government officials –e.g., U.S. Microbicide Development Act Advocacy for rectal microbicides

Global Campaign for Microbicides A worldwide effort co-sponsored by groups working on HIV/AIDS reproductive health gay health women’s empowerment Working to educate, raise awareness and generate collective advocacy for increased political and public investment in microbicide development

New strategy to raise awareness and demand among gay men Three components: Internet – Public presence in forums & conferences Media – print, electronic, guerilla! LifeLube.org

International Rectal Microbicides Working Group Working Collaboratively: Global listserv Bi-monthly conference calls Developed an advocacy agenda To join, contact Jim Pickett, Presence at conferences: –Microbicides 2006 conference –Gay Men’s Health Conferences –Gay and Lesbian Medical Association annual meeting

What you can do Visit or to Join the International Rectal Microbicide Working Group calls and listserve Learn more about rectal microbicides Sign up for the Global Campaign’s newsletter Host a talk on microbicides – this and other presentations available for download Endorse the Global Campaign